Abbas Shakila, Younus Malaika, Bukhari Ayesha, Anwar Mahnoor, Iqrar Aalia
Optometry, The University of Faisalabad, Faisalabad, Pakistan.
Strabismus. 2025 Mar;33(1):1-5. doi: 10.1080/09273972.2024.2389228. Epub 2024 Aug 19.
Amblyopia is two Snellen line difference between both eyes. Red filter therapy is a treatment option for amblyopia based on principle of syntonic phototherapy. The purpose of this study is to assess the stereopsis in amblyopic patient using syntonic phototherapy.
A Qusai experimental study was conducted from August 2021 to December 2021 at Madina Teaching Hospital Faisalabad. A total 30 subjects of both gender and ages ranging between 8 to 18 years were included through a non-probability purposive sampling technique. The sample was considered of 15 anisometropic amblyopes and 15 strabismic amblyope. Data was collected using a Performa and pre assessments of stereopsis by Titmus fly chart were recorded without red filter. Red filter glasses were prescribed for 4 week, post assessment data was recorded after 4 weeks. Data was analyzed by using Paired sample T test and Independent Sample T test in SPSS 20 software.
After syntonic phototherapy significant improvement was seen, mean stereopsis was 48.00000 ( = 0.002) in anisometropic amblyopes while mean improvement of stereopsis 1.670.93333 ( = 0.00) in strabismic amblyopes. Anisometropic amblyopic patients showed significantly better improvement in stereopsis ( = 0.00) by syntonic phototherapy as compared to strabismic amblyopes.
Significant improvement was seen in stereopsis, while improvement was more significant in anisometropic amblyopes as compared to strabismic amblyopes. Children were obsessed with the red filter glasses while their parents found syntonic therapy simple plus facile and gave good results. So, eye care professionals must be aware of this new therapy and they should keep syntonic phototherapy in mind whenever they are dealing with amblyopic patients.
弱视是双眼视力相差两行Snellen视力表视标。红色滤光片疗法是基于同步光疗法原理的一种弱视治疗方法。本研究的目的是评估使用同步光疗法的弱视患者的立体视觉。
2021年8月至2021年12月在费萨拉巴德麦地那教学医院进行了一项库赛实验研究。通过非概率目的抽样技术纳入了30名年龄在8至18岁之间的男女受试者。样本包括15名屈光参差性弱视患者和15名斜视性弱视患者。使用一份表格收集数据,并在不使用红色滤光片的情况下通过Titmus蝇标图对立体视觉进行预评估记录。开具红色滤光眼镜佩戴4周,4周后记录评估后的数据。在SPSS 20软件中使用配对样本t检验和独立样本t检验对数据进行分析。
同步光疗法后有显著改善,屈光参差性弱视患者的平均立体视觉为48.00000(P = 0.002),而斜视性弱视患者的立体视觉平均改善为1.67±0.93333(P = 0.00)。与斜视性弱视患者相比,屈光参差性弱视患者通过同步光疗法在立体视觉方面的改善显著更好(P = 0.00)。
立体视觉有显著改善,与斜视性弱视患者相比,屈光参差性弱视患者的改善更显著。孩子们对红色滤光眼镜很着迷,而他们的父母发现同步疗法简单易行且效果良好。因此,眼科护理专业人员必须了解这种新疗法,并且在处理弱视患者时应牢记同步光疗法。